ID Number 627

References this file:

0534_cclm-2021-0283_Within-_and_between-subject_biological_variation_data_for_tumor_markers_based_on_the_European_Biological_Variation_Study.pdf

Used in the following measurand datasets 35

• Carcinoembryonic antigen (CEA)
• Carcinoembryonic antigen (CEA)
• Carcinoembryonic antigen (CEA)
• Carcinoembryonic antigen (CEA)
• Carcinoembryonic antigen (CEA)
• Carcinoembryonic antigen (CEA)
• Carcinoembryonic antigen (CEA)
• Cyfra21-1
• Cyfra21-1
• Cyfra21-1
• Cyfra21-1
• Cyfra21-1
• Cancer antigen 19-9 (CA 19-9)
• Cancer antigen 19-9 (CA 19-9)
• Cancer antigen 19-9 (CA 19-9)
• Cancer antigen 19-9 (CA 19-9)
• Cancer antigen 19-9 (CA 19-9)
• Cancer antigen 15-3 (CA 15.3)
• Cancer antigen 15-3 (CA 15.3)
• Cancer antigen 15-3 (CA 15.3)
• Cancer antigen 15-3 (CA 15.3)
• Cancer antigen 15-3 (CA 15.3)
• Cancer antigen 125 (CA-125)
• Cancer antigen 125 (CA-125)
• Cancer antigen 125 (CA-125)
• Human epididymis protein 4 (HE4)
• Human epididymis protein 4 (HE4)
• Human epididymis protein 4 (HE4)
• Human epididymis protein 4 (HE4)
• Human epididymis protein 4 (HE4)
• Alphafetoprotein
• Alphafetoprotein
• Alphafetoprotein
• Alphafetoprotein
• Alphafetoprotein